185 related articles for article (PubMed ID: 36584198)
1. Clinical features and outcomes of breakthrough vitreous hemorrhage secondary to polypoidal choroidal vasculopathy.
Li MS; Tsen CL
PLoS One; 2022; 17(12):e0279778. PubMed ID: 36584198
[TBL] [Abstract][Full Text] [Related]
2. THE INCIDENCE, CHARACTERISTICS, MANAGEMENT, PROGNOSIS, AND CLASSIFICATION OF BREAKTHROUGH VITREOUS HEMORRHAGE SECONDARY TO POLYPOIDAL CHOROIDAL VASCULOPATHY.
Zhao XY; Luo MY; Meng LH; Zhang WF; Li B; Wang EQ; Liu SZ; Yu WH; Chen YX
Retina; 2021 Aug; 41(8):1675-1685. PubMed ID: 33395221
[TBL] [Abstract][Full Text] [Related]
3. Visual outcomes of vitrectomy for polypoidal choroidal vasculopathy-related breakthrough vitreous haemorrhage.
Lin HC; Yang CH; Yang CM;
Eye (Lond); 2014 Jul; 28(7):797-806; quiz 807. PubMed ID: 24924445
[TBL] [Abstract][Full Text] [Related]
4. Hemorrhagic complications after photodynamic therapy for polypoidal choroidal vasculopathy.
Hirami Y; Tsujikawa A; Otani A; Yodoi Y; Aikawa H; Mandai M; Yoshimura N
Retina; 2007 Mar; 27(3):335-41. PubMed ID: 17460589
[TBL] [Abstract][Full Text] [Related]
5. Surgical outcomes of vitrectomy for breakthrough vitreous hemorrhage in eyes with exudative age-related macular degeneration.
Iwase T; Baba T; Saito Y; Nizawa T; Yokouchi H; Kubota-Taniai M; Kitahashi M; Yamamoto S
Int Ophthalmol; 2021 May; 41(5):1835-1844. PubMed ID: 33611763
[TBL] [Abstract][Full Text] [Related]
6. Visual outcomes of early and late vitrectomy for breakthrough vitreous hemorrhage associated with exudative age-related macular degeneration and polypoidal choroidal vasculopathy.
Jirarattanasopa P; Khongsakdinasarn N; Ratanasukon M; Bhurayanontachai P; Dangboon Tsutsumi W
Medicine (Baltimore); 2023 Oct; 102(40):e35364. PubMed ID: 37800778
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of polypoidal choroidal vasculopathy with and without hemorrhage treated by anti-VEGF monotherapy.
Iwasaki M; Kobayashi K; Aoki S; Miyamoto H; Imaizumi H
Graefes Arch Clin Exp Ophthalmol; 2021 Jul; 259(7):1741-1750. PubMed ID: 33409679
[TBL] [Abstract][Full Text] [Related]
8. Results of vitrectomy for breakthrough vitreous hemorrhage associated with age-related macular degeneration and polypoidal choroidal vasculopathy.
Jung JH; Lee JK; Lee JE; Oum BS
Retina; 2010 Jun; 30(6):865-73. PubMed ID: 20182402
[TBL] [Abstract][Full Text] [Related]
9. Chinese Guideline on the Management of Polypoidal Choroidal Vasculopathy (2022).
Chen YX; Zhang YQ; Chen CZ; Dai H; Li SY; Ma X; Sun XD; Tang SB; Wang YS; Wei WB; Wen F; Xu GZ; Yu WH; Zhang MX; Zhao MW; Zhang Y; Qi F; Xu X; Li XX
Chin Med Sci J; 2023 Jun; 38(2):77-93. PubMed ID: 37263796
[TBL] [Abstract][Full Text] [Related]
10. Vitreous haemorrhage in massive hemorrhagic polypoidal choroidal vasculopathy: clinical characteristics and surgical outcomes: Vitreous hemorrhage in PCV.
Narayanan R; Mithal K; Jalali S; Chhablani JK; Mathai A; Ali MH
Int J Retina Vitreous; 2015; 1():25. PubMed ID: 27847618
[TBL] [Abstract][Full Text] [Related]
11. Visual Recovery and Prognosis in the Treatment of Submacular Hemorrhage due to Polypoidal Choroidal Vasculopathy and Retinal Arterial Macroaneurysm: A Retrospective Study.
Wu J; Yan T; Zhang R; Feng C; Xu C; Xu T; Li Y; Wang S; He J
Int J Clin Pract; 2023; 2023():3880297. PubMed ID: 37342617
[TBL] [Abstract][Full Text] [Related]
12. Hemorrhagic complications after intravitreal ranibizumab injection for polypoidal choroidal vasculopathy.
Cho HJ; Lee DW; Cho SW; Kim CG; Kim JW
Can J Ophthalmol; 2012 Apr; 47(2):170-5. PubMed ID: 22560424
[TBL] [Abstract][Full Text] [Related]
13. Incidence, outcomes, and risk factors for hemorrhagic complications in eyes with polypoidal choroidal vasculopathy following photodynamic therapy in Indian subjects.
Rishi P; Rishi E; Sharma M; Maitray A; Bhende M; Gopal L; Sharma T; Ratra D; Sen P; Bhende P; Rao C; Susvar P
Indian J Ophthalmol; 2017 Aug; 65(8):712-718. PubMed ID: 28820157
[TBL] [Abstract][Full Text] [Related]
14. Ultrasonographic characteristics and treatment outcomes of surgery for vitreous hemorrhage in idiopathic polypoidal choroidal vasculopathy.
Jalali S; Parra SL; Majji AB; Hussain N; Shah VA
Am J Ophthalmol; 2006 Oct; 142(4):608-19. PubMed ID: 17011853
[TBL] [Abstract][Full Text] [Related]
15. Periocular triamcinolone acetonide injection for treating polypoidal choroidal vasculopathy concurrent with hemorrhagic retinal detachment.
Zhang K; Chen Y; Sun X; Zhong Q; Lin L; Gao Y; Hong F
Medicine (Baltimore); 2018 Sep; 97(39):e12464. PubMed ID: 30278530
[TBL] [Abstract][Full Text] [Related]
16. Fibrovascular pigment epithelial detachment in eyes with subretinal hemorrhage secondary to neovascular AMD or PCV: a morphologic predictor associated with poor treatment outcomes.
Kim JH; Kim JY; Lee DW; Kim CG; Kim JW
Sci Rep; 2020 Sep; 10(1):14943. PubMed ID: 32913279
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal Tissue Plasminogen Activator, Ranibizumab, and Gas Injection for Submacular Hemorrhage in Polypoidal Choroidal Vasculopathy.
Kitagawa Y; Shimada H; Mori R; Tanaka K; Yuzawa M
Ophthalmology; 2016 Jun; 123(6):1278-86. PubMed ID: 26949121
[TBL] [Abstract][Full Text] [Related]
18. Long-term observation of vitrectomy without subretinal hemorrhage management for massive vitreous hemorrhage secondary to polypoidal choroidal vasculopathy.
Li ZX; Hu YJ; Atik A; Lu L; Hu J
Int J Ophthalmol; 2019; 12(12):1859-1864. PubMed ID: 31850169
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous intravitreal aflibercept and gas injections for submacular hemorrhage secondary to polypoidal choroidal vasculopathy.
Wakabayashi T; Hara C; Shiraki A; Shiraki N; Sayanagi K; Sakimoto S; Sato S; Sakaguchi H; Nishida K
Graefes Arch Clin Exp Ophthalmol; 2023 Jun; 261(6):1545-1552. PubMed ID: 36473986
[TBL] [Abstract][Full Text] [Related]
20. Polypoidal choroidal vasculopathy: natural history.
Uyama M; Wada M; Nagai Y; Matsubara T; Matsunaga H; Fukushima I; Takahashi K; Matsumura M
Am J Ophthalmol; 2002 May; 133(5):639-48. PubMed ID: 11992861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
